A Cutting-Edge Cancer Treatment May Cause Cancer. The FDA Is Investigating

CAR-T cell therapy harnesses the immune system to attack blood cancers. Six years after approving the first treatment, the FDA is investigating whether it can give rise to secondary cancers.

Prostate Cancer

Kris Atkins on LinkedIn: Looking forward to working closely with the entire OneOncology Network.

Dr. Rao Papineni on LinkedIn: #papinenilabs #msramiah #nci #sbir #cancer #nih #aacr #rrs #bcm #niaid…

Opdivo® (nivolumab) Approved as Adjuvant Treatment for Eligible Patients with Completely Resected Stage IIB or Stage IIC Melanoma - AIM at Melanoma Foundation

Biotech, Latest News, Photos & Videos

Wafik S. El-Deiry, MD, PhD, FACP on LinkedIn: A Cutting-Edge Cancer Treatment May Cause Cancer. The FDA Is Investigating…

Disparities in Clinical Research and Cancer Treatment

The role of autoantibodies biomarkers in precision medicine

Dr. Rao Papineni on LinkedIn: A Cutting-Edge Cancer Treatment May Cause Cancer. The FDA Is Investigating

Gene Therapy, Latest News, Photos & Videos